Home › Calculator › NERV Dividend Calculator 2026
NERV Dividend DRIP Calculator 2026
45.77% YieldHealthcareMinerva Neurosciences, Inc. · NASDAQ
Price: $4.37 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NERV pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NERV snowball 📈
$10,000 in NERV → $757403508.42M in 10 years · $62,982,567,521,021.49/month
About Minerva Neurosciences, Inc. (NERV) — Dividend Analysis 2026
Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system. Its portfolio of experimental treatments notably features roluperidone, an investigational drug aimed at managing schizophrenia, alongside MIN-301, a soluble recombinant variant of the neuregulin-1b1 protein, which is being explored for its potential in treating Parkinson's disease and various other neurodegenerative conditions. The company has a contractual licensing agreement with Mitsubishi Tanabe Pharma Corporation, authorizing the worldwide development, distribution, and import of roluperidone, with the explicit exclusion of the Asian continent. Established in 2007, this organization initially operated as Cyrenaic Pharmaceuticals, Inc. before undergoing a name change to Minerva Neurosciences, Inc. in 2013. Its corporate headquarters are located in Waltham, Massachusetts.
Compare NERV with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NERV DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NERV position with:
🌍 NERV Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NERV.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 45.77% | 42.97% | $4,577 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 38.90% | 36.10% | $3,890 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 36.62% | 33.82% | $3,662 / yr |
| 🇬🇧 UK ISA | 0% | 45.77% | 42.97% | $4,577 / yr |
| 🇬🇧 UK Taxable | 8.75% | 41.77% | 38.97% | $4,177 / yr |
| 🇨🇦 TFSA | 0% | 45.77% | 42.97% | $4,577 / yr |
| 🇨🇦 CA Taxable | 25% | 34.33% | 31.53% | $3,433 / yr |
| 🇦🇺 Super (pension) | 15% | 38.90% | 36.10% | $3,890 / yr |
| 🇦🇺 AU Taxable | 30% | 32.04% | 29.24% | $3,204 / yr |
| 🇩🇪 DE Taxable | 26.375% | 33.70% | 30.90% | $3,370 / yr |
| 🇫🇷 FR Taxable | 30% | 32.04% | 29.24% | $3,204 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NERV Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NERV Dividend Payment Schedule
NERV pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NERV vs Healthcare Benchmarks
How NERV compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NERV sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NERV Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-03 | 680,000 | $4.68 | $3.18M | ||
| A-Award | 2026-06-03 | 1,690,700 | $4.68 | $7.91M | ||
| A-Award | 2026-06-03 | 50,000 | $4.68 | $234.0K | ||
| A-Award | 2026-06-03 | 50,000 | $4.68 | $234.0K | ||
| A-Award | 2026-06-03 | 50,000 | $4.68 | $234.0K | ||
| A-Award | 2026-06-03 | 50,000 | $4.68 | $234.0K | ||
| A-Award | 2026-06-03 | 50,000 | $4.68 | $234.0K | ||
| A-Award | 2026-04-21 | 350,800 | $6.97 | $2.45M | ||
| A-Award | 2026-03-31 | 12,169 | $6.03 | $73.4K | ||
| A-Award | 2025-12-22 | 50,000 | $3.98 | $199.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NERV dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Minerva Neurosciences, Inc. (NERV) is currently trading at $4.37, 84% below its 52-week high. The current dividend yield is 45.77% based on an annual payout of $2.00 per share.
NERV (Minerva Neurosciences, Inc.) — 45.77% Dividend Yield Analysis
Minerva Neurosciences, Inc. (NERV) is a healthcare stock currently trading at $4.37 with a dividend yield of 45.77%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (45.77%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.